Identity
BPC-157 confirmedLC-MS identity result
COMPOUND IQRESEARCH. TESTED. EXPLAINED.Scan your COADOCUMENT REVIEW · SEPTEMBER 2026
Oath Research BPC-157: five documented categories and a date discrepancy.
We reviewed Freedom Diagnostics certificate accession 2607221019 for Oath Research BPC-157 10 mg, lot B2826025, reported July 26, 2026.
Compound IQ has no affiliate, sponsorship, compensation, or commercial relationship with Oath Research. We did not purchase or independently test this lot. This review evaluates one public supplier record and its linked laboratory certificate—not the company’s entire catalog or the product’s suitability for any use.
WHAT THE CERTIFICATE REPORTS
5 of 7 evidence categories documented.
Oath Research's lot page and the Freedom Diagnostics certificate align on the client, product, 10 mg label, lot, accession, 99.84% purity, 10.97 mg net content, and endotoxin results. Their displayed dates do not fully align. Reference: ACCESSION 2607221019 · LOT B2826025 · CODE Oath2607221019.
Purity
99.84%HPLC with UV detectionMeasured quantity
10.97 mgNet-content result for a sample labeled 10 mgLot traceability
B2826025Client, product, lot, accession, search code, receipt date, and report date appearSterility
Not reportedNo sterility or microbial result on this certificateEndotoxin
Pass × 2USP <85>-referenced LAL assay · sensitivity ≤0.05 EU/mLContaminants
Not reportedNo heavy-metal, residual-solvent, adulterant, or broader contaminant panelThe reported net content is 9.7% above the 10 mg label. The certificate reports the measurement but does not state a numerical content acceptance range or assign a content pass/fail decision.
WHAT THE HEADLINE DOES NOT SAY
Four limits that belong beside the score.
Sterility is not reported
The certificate contains no microbial or sterility result. LC-MS identity, HPLC-UV purity, and endotoxin testing do not answer that separate question.
No broader contaminant panel appears
The reviewed report does not show heavy metals, residual solvents, targeted adulterants, or another broader contaminant screen.
The public dates conflict
The supplier page describes the batch as tested and issued on July 22, while the certificate says it was received July 22 and reported July 26. The lot and accession align, but the reporting date should be presented from the certificate itself.
The submitted sample may not be current inventory
Oath Research states that batches rotate and an order is not necessarily from the reviewed batch. The supplier appears as the client, and the documents do not show independent random sampling from saleable inventory.
COMPOUND IQ VERDICT
Useful lot-specific core evidence, with two missing panels and one date conflict.
The public record supports five document categories for the submitted sample: LC-MS identity, 99.84% HPLC-UV purity, 10.97 mg measured content, lot traceability, and two passing endotoxin replicates. It does not report sterility or a broader contaminant panel, and the supplier page compresses the certificate timeline into a July 22 test date even though the PDF reports July 26. The 5/7 score describes visible document coverage—not product safety, supplier quality, or suitability for use.
SOURCE DOCUMENTS
Inspect the evidence directly.
Read the original certificate, match any current vial to its exact lot, and do not extend this result to another batch or product.
TAKE THE FRAMEWORK WITH YOU
Review the next supplier with the same seven checks.
Download the Compound IQ checklist before opening another certificate. It keeps identity, content, lot traceability, methods, and missing panels visible.
Instant PDF access. By subscribing, you agree to receive Compound IQ research education and occasional partner updates. Unsubscribe anytime.